Shingles vaccine and dementia risk: promising signal, not proof

A new June 2026 study is fueling a question many adults 50 and older may soon hear: could the shingles vaccine help protect brain health, too?

For now, the careful answer is maybe—but it is too soon to count on that benefit. In the United States, the proven reason to get Shingrix is still the one the Centers for Disease Control and Prevention already recommends it for: preventing shingles and complications such as long-lasting nerve pain.

What the new June 2026 study found

The study, published June 16, 2026 in Annals of Internal Medicine, looked at 509,926 Medicare fee-for-service beneficiaries age 66 and older who had recently been admitted to a skilled nursing facility and did not already have a dementia diagnosis.

Researchers used a method called a target trial emulation. That is an observational study design that tries to make real-world data behave more like a clinical trial, but it is still not the same as randomly assigning people to get vaccinated or not.

According to the PubMed abstract, adults who received at least one dose of recombinant zoster vaccine (RZV, sold as Shingrix) during the facility stay or within 12 months afterward had a lower 4-year dementia risk than similar adults who did not get the vaccine. The reported 4-year dementia risk was 18.8% in the vaccinated group versus 24.6% in the unvaccinated group, a difference of 5.8 percentage points. The study reported a risk ratio of 0.76, meaning vaccination was associated with about a 24% lower relative risk over the follow-up period.

That is an important signal. But it is still an association, not proof that the vaccine itself prevents dementia.

What the shingles vaccine is already for

CDC guidance is clear about the vaccine’s established purpose. In the U.S., Shingrix is the shingles vaccine in use, and it is recommended to prevent shingles and related complications.

CDC recommends Shingrix for:

Adults 50 and older
Adults 19 and older who have weakened immune systems because of disease or therapy

For most adults 50 and older, it is given as a 2-dose series 2 to 6 months apart. CDC also says people should still get vaccinated even if they have had shingles before, previously got the older Zostavax vaccine, or received chickenpox vaccine.

The most common side effects are short term: a sore arm, redness or swelling where the shot was given, tiredness, muscle aches, headache, fever, chills, stomach pain, and nausea. These reactions can be unpleasant, but they usually go away within a few days.

Why researchers are studying dementia risk at all

This question is not coming out of nowhere. The National Institutes of Health held a dedicated virtual workshop on June 1–2, 2026 called Zoster Vaccine and Dementia Risk Reduction: Evidence and Mechanisms.

In the workshop announcement, the National Institute on Aging said the meeting would review the growing epidemiologic evidence, possible biological mechanisms, available data sets, and what kinds of future studies would be needed to test whether any true clinical benefit exists. NIH’s decision to convene a workshop on the topic shows the question is scientifically serious. It does not mean the answer is settled.

Why this is promising—but not practice-changing

There are several reasons not to treat the new finding as a green light to use Shingrix as a dementia-prevention strategy.

The study was observational. A target trial emulation can strengthen this kind of research, but it cannot fully rule out hidden differences between people who got vaccinated and people who did not.
The authors reported possible residual confounding. In plain language, that means unmeasured factors may still have influenced the results.
The study population was narrow. These were older adults after a skilled-nursing-facility stay, so the results may not apply the same way to healthier adults living in the community.
The mechanism is still unclear. If the association is real, researchers still do not know whether it reflects prevention of shingles itself, changes in inflammation, the vaccine’s adjuvant, or something else.
It was industry funded. The PubMed abstract lists GlaxoSmithKline, the maker of Shingrix, as the primary funding source. That does not invalidate the research, but it is an important piece of context.

The bottom line: this is encouraging research, but it does not change today’s standard advice.

Why shingles prevention still matters for brain and nerve health

Even if the dementia question remains unsettled, preventing shingles still matters. CDC notes that shingles can lead to postherpetic neuralgia, a painful nerve complication that can last for months or even years.

The American Heart Association also says shingles has been linked to higher risk of cardiovascular events such as stroke and heart attack, and notes that rare complications can include brain inflammation. That does not prove shingles vaccination prevents dementia. It does reinforce that avoiding shingles can matter for overall neurologic and vascular health.

What adults 50 and older should do now

If you are 50 or older, check whether you have completed the 2-dose Shingrix series.
If you are 19 or older and immunocompromised, ask whether you should get it sooner.
Do not treat Shingrix as an established dementia-prevention shot. That is not what U.S. recommendations currently say.
Do use it for its proven benefit: reducing the risk of shingles and painful complications.
If you are unsure about timing, prior shingles, or other vaccines, ask a clinician or pharmacist.

Cost and access

For many older adults, access may be easier than it once was. Medicare says the shingles vaccine is covered under Part D, and people with Part D pay nothing for the vaccine. Outside Medicare, coverage can still vary by plan, provider, and state, including for Medicaid and private insurance, so it is reasonable to check before your appointment.

When to get medical help

If you develop a new painful blistering rash, contact a clinician promptly, especially if you are older or have a weakened immune system. Early treatment for shingles can help reduce complications.

If you have possible stroke symptoms—such as sudden face drooping, arm weakness, trouble speaking, sudden vision loss, or severe imbalance—call 911 right away.

And if you are weighing the vaccine mainly because of dementia headlines, the most reasonable next step is simple: ask your doctor or pharmacist what current CDC guidance says for your age, health history, and insurance coverage.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.